The median OS (the time from primary breast cancer diagnosis to the date of death or the end of follow-up) and post-recurrent survival (the time from metastatic breast cancer diagnosis to the date of death or the end of follow-up) was calculated on the basis of ER status in the primary tumor and metastatic tissues (Table 3). The gene discussed is ESR1; the disease is breast carcinoma.